September 22, 2014
Wellesley, Mass., September 22, 2014 –BCC Research (www.bccresearch.com) reveals in its new report, AUTOIMMUNE DISEASE DIAGNOSTICS: GLOBAL MARKETS, the global market for autoimmune disease diagnostics is expected to grow to nearly $13.1 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.6%. Southern Asia holds the highest market potential due to an increasing number of environmental factors and adoption of western lifestyles.
In recent decades, autoimmune diseases have emerged particularly in regions not previously associated with autoimmune risk, namely urban residential areas in Africa, Southern and Eastern Europe, Asia and Latin America. This emergence is attributed to environmental factors and western lifestyles. Among other factors, sunlight (UVR) exposure, nutritional habits, xenobiotics and hygiene have been identified as leading causes to date.
As a region, Southern Asia tops the list with a market potential of nearly $2.8 billion in 2014. It is followed by Europe and North America at about $2.7 billion and nearly $2.5 billion, respectively. Despite having lower incidence and prevalence rates, the market size of Southern Asia is sizable due to its large population.
“Western countries are being confronted with a disturbing increase in the incidence of autoimmune disorders,” says BCC Research pharmaceutical analyst Anandi Karumbati. “Dietary factors, sunlight exposure, improved hygiene, along with environmental factors, are attributed to this emergence.”
AUTOIMMUNE DISEASE DIAGNOSTICS: GLOBAL MARKETS provides a thorough background of the structure of the autoimmune disease diagnostics market and outlines the chief challenges and opportunities it faces. Forecast revenues are presented from 2014 through 2019. In addition, market size by various segments, namely geographic regions, gender and disease phase (pre-treatment and in-treatment) is included.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at firstname.lastname@example.org.
Autoimmune Disease Diagnostics: Global Markets( PHM160A )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email email@example.com or visit www.bccresearch.com/media to request access to our library of market research.